PEDIATRIC HEMATOLOGY/ONCOLOGY FACULTY AND FELLOWS
FACULTYSENIOR FELLOWS/ACTING INSTRUCTORS/ACTING ASSISTANT PROFESSORS
Tina Albertson, MD
Marie Bleakley, MD
Lauri Burroughs, MD
Eric Chow, MD MPH
Scott Diede, MD PhD
Rebecca Emmons, MD
Phoenix Ho, MD
Jessica Pollard, MD
PEDIATRIC ONCOLOGY FELLOWSHIP TRAINING PROGRAM
The University of Washington (UW) Department of Pediatrics and the Fred Hutchinson Cancer Research Center (FHCRC) offer a three-year ACGME accredited Pediatric Hematology and Oncology Fellowship Training Program (Training Program). The overall aim of the Pediatric Oncology Program is to improve the outcome for children with malignancy. The Pediatric Hematology/Oncology Training is designed to encourage and train both clinical and laboratory investigators. This comprehensive training utilizes faculty and resources at University of Washington, Seattle Children's and Fred Hutchinson Cancer Research Program. The fellowship is funded by training grant from the National Cancer Institute of the National Institutes of Health and from institutional sources.
The Pediatric Hematology/Oncology Training Program provides an interdisciplinary program in clinical cancer research and basic research in cancer biology and therapy as related to transplantation biology, immunology, genetic engineering and gene therapy, solid tumor biology, experimental chemotherapy and mechanisms of drug resistance, and the nature and control of normal and malignant hematopoiesis. Ongoing research within the Pediatric Hematology/Oncology program is focused on developmental aspects of hematopoiesis, including hematopoietic stem cell expansion, immune reconstitution following hematopoietic stem cell transplant and molecular analyses of normal and malignant hematopoiesis; neuro-onology and pediatric solid tumor research including growth and differentiation of normal and malignant tissues and mechanisms of chemoresistance; and additional interdisciplinary research involving nanotechnology and molecular imaging for neurologic disease and solid tumor diagnosis, treatment, and response evaluation.
Clinical research investigations are ongoing in areas of bone marrow transplantation, general oncology, hematology, chemotherapy pharmacokinetic and pharmacogenetic interactions, cancer epidemiology and late effects of therapy. Novel therapeutic regimens for treatment of graft versus host disease, AML, sarcomas, brain tumors and neuroblastoma are underway. Our clinical investigators are actively involved in the Children's Oncology Group consortium, Pediatric Brain Tumor Consortium, and Novel Advances in Neuroblastoma Therapy Consortium. Our clinical investigators are leading protocol development for treatment of sarcoma, neuroblastoma, Hodgkins disease, retinoblastoma, lymphoma, AML, brain tumors, and late effects. Our epidemiology, late effects, and secondary malignancy research represents collaborations between investigators at Children's, Clinical Sciences, and Public Health Sciences (PHS) at the Fred Hutchinson Cancer Research Center and the Schools of Public Health and Medicine at the University.
The Division of Pediatric Hematology/Oncology is part of the Department of Pediatrics, University of Washington and the Clinical Division, Fred Hutchinson Cancer Research Center and is a component of the Seattle Cancer Care Alliance (SCCA). The Fred Hutchinson program was begun by Dr. E. D. Thomas in 1963 and was particularly honored in 1990 when Dr. Thomas was awarded the Nobel Prize for his contributions in the immunology of marrow transplantation. Seattle Children's is a nationally recognized comprehensive academic pediatric medical facility that serves pediatric patients in the Northwest region including Washington, Alaska, Montana, and Idaho. The entire Seattle Cancer Program (medical and pediatric) includes over 125 M.D. and Ph.D. faculty members and the necessary support personnel. The Pediatric program includes 18 MD faculty, eight Advanced Practice Nurses, and five Physician Assistants. Approximately 250 patients are diagnosed with malignancies and cared for at Children's annually. Approximately 50 pediatric patients undergo HCT annually.
Length of Training Program
Fellows who have completed three years in general pediatrics training are eligible for participation in the Training Program. Successful completion of this three-year ACGME accredited program will lead to ABP board eligibility in Pediatric Hematology Oncology. The first year focuses on clinical training; the second and third years are primarily research-based. Fellows are encouraged to begin the process of seeking outside funding in their third year. For fellows who wish continue their research after completing the Training Program, they are required to seek outside support and may also receive support from preceptors' individual research grant funds.
First Year in the Training Program
(See: clinical rotations for first-year pediatric fellows)
Fellows are selected on the basis of interest in developing careers in academic medicine. The first year of the program is devoted to clinical training in Pediatric Hematology and Oncology. The clinical program consists of two integrated but separate sub-programs: (1) general Hematology/Oncology and (2) Hematopoietic Stem Cell Transplantation. The predominant clinical site for general Hematology/Oncology sub-program is located at Seattle Children's where both in-patient and outpatient general hematology/oncology services are located. In addition, there is a monthly outpatient sickle cell clinic at Odessa Brown Children's Clinic in the central area of Seattle. The Hematopoietic Stem Cell Transplantation inpatient service is included within the Seattle Cancer Care Alliance (SCCA) and is located at Children's while the outpatient service is located at the SCCA outpatient clinic.
The clinical fellowship provides a thorough experience in the diagnosis and management of leukemias, lymphomas, and other solid malignant tumors of childhood. In addition it provides exposure to the management of congenital and acquired disorders of erythrocytes, leukocytes, platelets and coagulation factors and to the hematological problems of the newborn. The first year includes alternating responsibilities in the general hematology/oncology outpatient clinic, the inpatient hematology/oncology service, the inpatient stem cell transplant service at Seattle Children's, and the outpatient transplant clinic and late effects clinic at the Seattle Cancer Care Alliance. Fellows also augment their clinical training by participating in a comprehensive sickle cell clinic once monthly during their outpatient clinic rotation and by participating in a continuity clinic of primary hematology and oncology patients one ½-day each week throughout their fellowship training.
Licensure
Washington State Medical License
The state of Washington and the UW School of Medicine require that all physicians beyond their internship year have full license to practice medicine. Fellows who do not have a Washington license upon their arrival will not be permitted to begin their training and will not be paid. Information regarding licensure deadlines, reciprocal licensure and application forms may be obtained from the Washington State Department of Health, Professional Licensing Division by calling 360-236-4700, or writing PO Box 47866, Olympia, Washington 98504-7866. Online application forms are available at: https://fortress.wa.gov/doh/hpqa1/HPS5/Medical/forms.htm
DEA Certificate
Upon receiving their Washington State Department of Health issued MD license, the fellow must apply for a DEA license. The fellow will submit their completed application to the University of Washington GME office for processing. This will be a limited license that cannot be used outside the scope of the fellowship program. Information regarding DEA can be found at: http://www.deadiversion.usdoj.gov/drugreg/reg_apps/index.html
Health Clearance
Fellows must receive a "health clearance" from Seattle Children's and University of Washington prior to commencing their clinical service on July 1. Fellows will not be allowed to provide any patient care until this health clearance has been obtained. Fellows will be asked to provide documentation of health history, including PPD, MMR, Hep B, measles, etc., in the spring prior to entering the program.
HIPAA for Clinical Care
Clinical HIPAA certification is required in the first year. Fellows will be issued a password to access specific HIPAA clinical training modules.
Second and Third Years in the Training Program
Research Opportunities
The second and third years of the Training Program are primarily devoted to research training aimed at developing independent academic investigators. Following the initial year of clinical training, fellows receive training and experience in both basic research and clinical research. Each fellow has an individualized research program. The majority of fellows receive training in basic and/or preclinical laboratory based projects for two years. With input from the Division Head and Program Director, the fellow selects his/her laboratory mentor for laboratory and/or clinical research projects. The available programs at Fred Hutchinson Cancer Research Center, University of Washington, and Seattle Children's represent a wide variety of research opportunities. One of the strengths of the research component of the Training Program is the substantial interaction between the various research programs. Specific problems currently under investigation by the proposed preceptors are outlined as Programmatic Research Areas. There are essentially no administrative barriers between the Programmatic Research Areas and the FHCRC enjoys a tremendous spirit of collegiality and interaction between its investigators. The research projects selected are tailored to meet the needs of the individual fellows depending upon their interests, previous training, and experience.
While a formal curriculum is not offered, there is an extensive series of teaching conferences in which the fellows participate. These teaching conferences include discipline-oriented weekly conferences in transplantation immunology and molecular biology at the Fred Hutchinson Cancer Research Center and weekly division conference in molecular and clinical research at Seattle Children's. They also include conferences in biostatistics, bioethics, clinical pharmacology, immunology and other major disciplines through Fred Hutchinson Cancer Research Center, the University of Washington, and Seattle Children's.
Clinical Responsibilities
The 2nd and 3rd year fellows attend continuity clinic ½-day per week. They also take call approximately 3-4 times monthly during the second year and two times monthly during the third year; these are usually from home providing oversight of inpatient residents, and as consultant to families and referring physicians who call in after 5:00pm. The 3rd year fellows have one month on the transplant service - this is a month for continued training in transplant clinical issues and to provide them with increased responsibility in patient care to enable better transition to attending after completion of fellowship.
Moonlighting
Fellows in their second and third years of the Training Program are allowed to provide moonlighting coverage in accordance with UW moonlighting policies, as well as the ACGME Duty Hours requirements. Moonlighting is voluntary but must be approved by the Fellowship Program Director and the UW Office of Medical Education. Fellows must apply for a full DEA license at their own expense in order to moonlight. It is mandated that fellows may moonlight only once/weekly (Monday - Friday) and no more than two times in a seven-day period. Moonlighting is not allowed during the initial year of Pediatric Hematology/Oncology fellowship training. Upon completion of the Training Program, fellows are no longer eligible to provide moonlighting services.
HIPAA/Human Subjects/Research Ethics Training
Fellows must be trained and certified pursuant to HIPAA regulations. Clinical HIPAA certification is required in the first year. Research HIPAA training is required beginning with the second year. Human Subjects training is provided in the first year. Second and third year fellows must attend training in the responsible conduct of research. The UW School of Medicine has developed a program of lectures with associated discussion groups, entitled the Biomedical Research Integrity (BRI) Series, for fellows to meet this requirement.
Facilities
The FHCRC campus features state-of-the-art laboratory and clinical facilities (Seattle Cancer Care Alliance Clinic). Seattle Children's features recently remodeled oncology inpatient unit, Pediatric Intensive Care Unit, and hematology/oncology clinic. A dedicated 38-bed HEPA-filtered inpatient unit exists for care of hematology/oncology and transplant patients. An additional outpatient clinic area includes an infusion center and on-site anesthesia equipped sedation rooms.
The approximate total space available laboratory research and support space at the FHCRC is approximately 500,000 sq. ft.; laboratory space available at the UWMC offers approximately 4,000 sq. ft for research. The majority of proposed preceptors are involved with the clinical research program but also run independently funded laboratory research programs.
Shared Resources
FHCRC operates a large number of shared resources that provide routine services for a variety of research activities.
Application Details
Applications for the Pediatric Hematology/Oncology Program are through ERAS.
MyERAS web site opens to applicants to begin working on their applications on July 1, 2009. Applicants may submit their application November 15, 2009.
We require a minimum of three letters of recommendation and request that your personal statement be one page in length.
Application deadline:
January 15, 2010
Applicants must also register with the National Resident Matching Program (NRMP).
Interview schedule:
January 12 - April 8, 2010
PEDIATRIC ONCOLOGY FELLOWSHIP TRAINING PROGRAM CONTACT INFORMATION
For information contact:
Barbara Killam
Fellowship Coordinator
Fred Hutchinson Cancer Research Center
1100 Fairview Ave N, D2-373
P.O. Box 19024
Seattle, WA 98109-1024
206-667-1212
bkillam@fhcrc.org
1100 Fairview Ave. N. PO Box 19024 Seattle, WA 98109
©2009 Fred Hutchinson Cancer Research Center, a nonprofit organization.
Terms of Use & Privacy Policy.
